PAINREFORM LTD. financial data

Symbol
PRFX on Nasdaq
Location
Tel Aviv, Israel
Fiscal year end
31 December
Latest financial report
20-F - Q4 2024 - 07 Apr 2025

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1,471,412 shares -15%
Common Stock, Shares, Outstanding 2,013,141 shares -42%
Common Stock, Value, Issued $0 USD

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $3,479,000 USD 25%
Assets, Current $3,909,000 USD 31%
Property, Plant and Equipment, Net $26,000 USD -38%
Operating Lease, Right-of-Use Asset $58,000 USD -21%
Intangible Assets, Net (Excluding Goodwill) $7,119,000 USD
Assets $11,162,000 USD 259%
Employee-related Liabilities, Current $405,000 USD -8%
Accrued Liabilities, Current $1,831,000 USD -57%
Liabilities, Current $2,456,000 USD -50%
Operating Lease, Liability, Noncurrent $0 USD -100%
Liabilities $2,719,000 USD -47%
Retained Earnings (Accumulated Deficit) $58,767,000 USD -7.5%
Stockholders' Equity Attributable to Parent $8,443,000 USD
Liabilities and Equity $11,162,000 USD 259%

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 10,000,000 shares -50%
Common Stock, Shares, Issued 2,013,141 shares -42%
Common Stock, Par or Stated Value Per Share 0.3 ILS/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $3,494,000 USD 25%
Deferred Tax Assets, Valuation Allowance $10,246,000 USD 48%
Operating Lease, Liability, Current $56,000 USD -1.8%
Deferred Tax Assets, Operating Loss Carryforwards $7,964,000 USD 40%
Unrecognized Tax Benefits $263,000 USD 3.1%
Additional Paid in Capital $67,210,000 USD 28%
Deferred Tax Assets, Net of Valuation Allowance $0 USD